BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 33275150)

  • 21. An Economic Evaluation of Australia's Newborn Hearing Screening Program: A Within-Study Cost-Effectiveness Analysis.
    Sharma R; Gu Y; Sinha K; Ching TYC; Marnane V; Gold L; Wake M; Wang J; Parkinson B
    Ear Hear; 2022; 43(3):972-983. PubMed ID: 34772837
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Otoacoustic Emissions in Rural Nicaragua: Cost Analysis and Implications for Newborn Hearing Screening.
    Wong LY; Espinoza F; Alvarez KM; Molter D; Saunders JE
    Otolaryngol Head Neck Surg; 2017 May; 156(5):877-885. PubMed ID: 28457225
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Implementing neonatal screening for congenital cytomegalovirus: addressing the deafness of policy makers.
    de Vries JJ; Vossen AC; Kroes AC; van der Zeijst BA
    Rev Med Virol; 2011 Jan; 21(1):54-61. PubMed ID: 21246642
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A cost-effectiveness analysis of newborn hearing screening strategies.
    Kemper AR; Downs SM
    Arch Pediatr Adolesc Med; 2000 May; 154(5):484-8. PubMed ID: 10807300
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Screening for seemingly healthy newborns with congenital cytomegalovirus infection by quantitative real-time polymerase chain reaction using newborn urine: an observational study.
    Yamaguchi A; Oh-Ishi T; Arai T; Sakata H; Adachi N; Asanuma S; Oguma E; Kimoto H; Matsumoto J; Fujita H; Uesato T; Fujita J; Shirato K; Ohno H; Kizaki T
    BMJ Open; 2017 Jan; 7(1):e013810. PubMed ID: 28110288
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cost and cost-effectiveness of universal screening for hearing loss in newborns.
    Kezirian EJ; White KR; Yueh B; Sullivan SD
    Otolaryngol Head Neck Surg; 2001 Apr; 124(4):359-67. PubMed ID: 11283492
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Performance of Targeted Congenital Cytomegalovirus Screening in Newborns Failing Universal Hearing Screening: A Multicenter Study.
    Fourgeaud J; Boithias C; Walter-Nicolet E; Kermorvant E; Couderc S; Parat S; Pol C; Mousset C; Bussières L; Guilleminot T; Ville Y; Nkam L; Grimaldi L; Parodi M; Leruez-Ville M
    Pediatr Infect Dis J; 2022 Jun; 41(6):478-481. PubMed ID: 35093998
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cost-effectiveness and budget impact analyses of colorectal cancer screenings in a low- and middle-income country: example from Thailand.
    Phisalprapa P; Supakankunti S; Chaiyakunapruk N
    J Med Econ; 2019 Dec; 22(12):1351-1361. PubMed ID: 31560247
    [No Abstract]   [Full Text] [Related]  

  • 29. A rational approach to identifying newborns with hearing loss caused by congenital cytomegalovirus infection by dried blood spot screening.
    Moteki H; Isaka Y; Inaba Y; Motobayashi M; Nishio SY; Ohira S; Yano T; Iwasaki S; Shiozawa T; Koike K; Usami SI
    Acta Otolaryngol; 2018 Aug; 138(8):708-712. PubMed ID: 29513124
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cost-Effectiveness of Pediatric Cochlear Implantation in Rural China.
    Qiu J; Yu C; Ariyaratne TV; Foteff C; Ke Z; Sun Y; Zhang L; Qin F; Sanderson G
    Otol Neurotol; 2017 Jul; 38(6):e75-e84. PubMed ID: 28379918
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cost-effectiveness of cytomegalovirus vaccination for females in China: A decision-analytical Markov study.
    Yin MZ; Gu YY; Shu JT; Zhang B; Su M; Zhang LP; Jiang YH; Qin G
    Vaccine; 2023 Sep; 41(40):5825-5833. PubMed ID: 37580210
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytomegalovirus Screening in Pregnancy: A Cost-Effectiveness and Threshold Analysis.
    Albright CM; Werner EF; Hughes BL
    Am J Perinatol; 2019 Jun; 36(7):678-687. PubMed ID: 30567003
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cost-Effectiveness of Screening Preschool Children for Hearing Loss in Australia.
    Gumbie M; Parkinson B; Dillon H; Bowman R; Song R; Cutler H
    Ear Hear; 2022; 43(3):1067-1078. PubMed ID: 34753856
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Colorado newborn hearing screening project, 1992-1999: on the threshold of effective population-based universal newborn hearing screening.
    Mehl AL; Thomson V
    Pediatrics; 2002 Jan; 109(1):E7. PubMed ID: 11773575
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Newborn hearing screening: will children with hearing loss caused by congenital cytomegalovirus infection be missed?
    Fowler KB; Dahle AJ; Boppana SB; Pass RF
    J Pediatr; 1999 Jul; 135(1):60-4. PubMed ID: 10393605
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of molecular techniques in prediction and diagnosis of cytomegalovirus disease in immunocompromised patients.
    Szczepura A; Westmoreland D; Vinogradova Y; Fox J; Clark M
    Health Technol Assess; 2006 Apr; 10(10):1-176. PubMed ID: 16595079
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Estimated Cost-effectiveness of Endoscopic Screening for Upper Gastrointestinal Tract Cancer in High-Risk Areas in China.
    Xia R; Zeng H; Liu W; Xie L; Shen M; Li P; Li H; Wei W; Chen W; Zhuang G
    JAMA Netw Open; 2021 Aug; 4(8):e2121403. PubMed ID: 34402889
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Congenital Cytomegalovirus and Hearing Loss.
    Andronaco DW
    J Obstet Gynecol Neonatal Nurs; 2020 May; 49(3):293-304. PubMed ID: 32259513
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Domestic HPV vaccine price and economic returns for cervical cancer prevention in China: a cost-effectiveness analysis.
    Zou Z; Fairley CK; Ong JJ; Hocking J; Canfell K; Ma X; Chow EPF; Xu X; Zhang L; Zhuang G
    Lancet Glob Health; 2020 Oct; 8(10):e1335-e1344. PubMed ID: 32971056
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cost-effectiveness and test-performance factors in relation to universal newborn hearing screening.
    Gorga MP; Neely ST
    Ment Retard Dev Disabil Res Rev; 2003; 9(2):103-8. PubMed ID: 12784228
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.